1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Amgen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) Carfilzomib, Lenalidomide, Dexamethasone - Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | Enrolling by invitation | Landspitali University Hospital | 80 | 2019-06-24 | 2019-08-16 |
Multiple Myeloma (1) · Smoldering Multiple Myeloma (1)
Dexamethasone (1) · Lenalidomide (1) · carfilzomib (1)
Iceland (1)